Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2023-05-01 Sale | 2023-05-02 4:33 pm | Nurix Therapeutics Inc. | NRIX | Wolff Stefani EVP and COO | 342 | $9.8763 | $3,378 | 16,695 (Direct) | View |
| 2023-01-30 Sale | 2023-02-01 4:18 pm | Nurix Therapeutics Inc. | NRIX | Wolff Stefani EVP and COO | 424 | $11.78 | $4,995 | 15,484 (Direct) | View |
| 2022-10-31 Sale | 2022-11-01 7:32 pm | Nurix Therapeutics Inc. | NRIX | Wolff Stefani EVP and COO | 350 | $12.88 | $4,508 | 15,908 (Direct) | View |
| 2022-08-01 Sale | 2022-08-02 5:48 pm | Nurix Therapeutics Inc. | NRIX | Wolff Stefani EVP and COO | 356 | $15.67 | $5,579 | 14,706 (Direct) | View |
| 2022-05-02 Sale | 2022-05-03 7:04 pm | Nurix Therapeutics Inc. | NRIX | Wolff Stefani EVP and COO | 330 | $11.75 | $3,878 | 15,062 (Direct) | View |
| 2020-06-15 Sale | 2020-06-17 9:52 pm | Principia Biopharma Inc. | PRNB | Wolff Stefani Chief Development Officer | 5,504 | $60.75 | $334,385 | 19,096 (Direct) | View |
| 2020-03-16 Sale(A) | 2020-06-17 9:48 pm | Principia Biopharma Inc. | PRNB | Wolff Stefani Chief Development Officer | 5,504 | $46.15 | $254,031 | 24,600 (Direct) | View |
| 2019-12-16 Sale(A) | 2020-06-17 9:41 pm | Principia Biopharma Inc. | PRNB | Wolff Stefani Chief Development Officer | 5,505 | $49.43 | $272,091 | 30,104 (Direct) | View |
| 2020-03-16 Sale | 2020-03-18 5:08 pm | Principia Biopharma Inc. | PRNB | Wolff Stefani Chief Development Officer | 5,504 | $46.15 | $254,031 | 54,656 (Direct) | View |
| 2019-12-16 Sale | 2019-12-18 7:09 pm | Principia Biopharma Inc. | PRNB | Wolff Stefani Chief Development Officer | 5,505 | $49.43 | $272,091 | 60,160 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-01-26 Disposition | 2024-01-26 4:50 pm | N/A N/A | Rain Oncology Inc. | RAIN | Wolff Stefani Director | 79,000 | $0 | 0 (Direct) | View |
| 2023-08-09 Option Award | 2023-08-11 9:09 pm | N/A 2033-08-09 | Rain Oncology Inc. | RAIN | Wolff Stefani Director | 35,000 | $0 | 35,000 (Direct) | View |
| 2023-04-30 Exercise | 2023-05-02 4:33 pm | N/A N/A | Nurix Therapeutics Inc. | NRIX | Wolff Stefani EVP and COO | 962 | $0 | 16,695 (Direct) | View |
| 2023-02-14 Option Award | 2023-02-15 4:14 pm | N/A 2033-02-13 | Nurix Therapeutics Inc. | NRIX | Wolff Stefani EVP and COO | 112,900 | $0 | 112,900 (Direct) | View |
| 2023-01-30 Exercise | 2023-02-01 4:18 pm | N/A N/A | Nurix Therapeutics Inc. | NRIX | Wolff Stefani EVP and COO | 962 | $0 | 15,484 (Direct) | View |
| 2022-10-30 Exercise | 2022-11-01 7:32 pm | N/A N/A | Nurix Therapeutics Inc. | NRIX | Wolff Stefani EVP and COO | 962 | $0 | 15,908 (Direct) | View |
| 2022-06-01 Option Award | 2022-08-19 5:38 pm | N/A 2032-06-01 | Rain Therapeutics Inc. | RAIN | Wolff Stefani Director | 20,000 | $0 | 20,000 (Direct) | View |
| 2022-08-09 Option Award | 2022-08-10 4:18 pm | N/A 2032-08-08 | Nurix Therapeutics Inc. | NRIX | Wolff Stefani EVP and COO | 110,375 | $0 | 110,375 (Direct) | View |
| 2022-07-30 Exercise | 2022-08-02 5:48 pm | N/A N/A | Nurix Therapeutics Inc. | NRIX | Wolff Stefani EVP and COO | 962 | $0 | 14,706 (Direct) | View |
| 2022-04-30 Exercise | 2022-05-03 7:04 pm | N/A N/A | Nurix Therapeutics Inc. | NRIX | Wolff Stefani EVP and COO | 962 | $0 | 15,062 (Direct) | View |
| 2022-01-19 Option Award | 2022-01-21 4:17 pm | N/A 2032-01-18 | Nurix Therapeutics Inc. | NRIX | Wolff Stefani EVP and COO | 50,023 | $0 | 50,023 (Direct) | View |
Ownership | 2021-08-17 5:19 pm | N/A 2031-07-12 | Nurix Therapeutics Inc. | NRIX | Wolff Stefani EVP and COO | 0 | $0 | 443,865 (Direct) | View |
| 2021-05-14 Option Award | 2021-05-18 5:44 pm | N/A 2031-05-14 | Rain Therapeutics Inc. | RAIN | Wolff Stefani Director | 24,000 | $0 | 24,000 (Direct) | View |
| 2020-09-18 Gift | 2020-09-28 5:19 pm | N/A N/A | Principia Biopharma Inc. | PRNB | Wolff Stefani Chief Development Officer | 5,504 | $0 | 0 (Direct) | View |
| 2020-09-28 Disposition | 2020-09-28 5:19 pm | N/A 2027-02-15 | Principia Biopharma Inc. | PRNB | Wolff Stefani Chief Development Officer | 238,958 | $0 | 0 (Direct) | View |
| 2020-09-28 Equity Swap | 2020-09-28 5:19 pm | N/A N/A | Principia Biopharma Inc. | PRNB | Wolff Stefani Chief Development Officer | 13,592 | $100 | 0 (Direct) | View |
| 2020-03-16 Exercise | 2020-03-18 5:08 pm | N/A 2027-02-15 | Principia Biopharma Inc. | PRNB | Wolff Stefani Chief Development Officer | 5,504 | $0 | 54,656 (Direct) | View |
| 2020-03-16 Exercise | 2020-03-18 5:08 pm | N/A N/A | Principia Biopharma Inc. | PRNB | Wolff Stefani Chief Development Officer | 5,504 | $4.542 | 54,656 (Direct) | View |
| 2020-03-05 Option Award | 2020-03-05 5:30 pm | N/A 2030-03-04 | Principia Biopharma Inc. | PRNB | Wolff Stefani Chief Development Officer | 55,000 | $0 | 55,000 (Direct) | View |
| 2019-12-16 Exercise | 2019-12-18 7:09 pm | N/A 2027-02-15 | Principia Biopharma Inc. | PRNB | Wolff Stefani Chief Development Officer | 5,505 | $0 | 60,160 (Direct) | View |
| 2019-12-16 Exercise | 2019-12-18 7:09 pm | N/A N/A | Principia Biopharma Inc. | PRNB | Wolff Stefani Chief Development Officer | 5,505 | $4.542 | 60,160 (Direct) | View |